Ding XQ - Search Results

1

Role of lysine187 within the second extracellular loop of the type A cholecystokinin receptor in agonist-induced activation. Use of complementary charge-reversal mutagenesis to define a functionally important interdomain interaction.

Dong M, Ding XQ, Thomas SE, Gao F, Lam PC, Abagyan R, Miller LJ. Dong M, et al. Among authors: ding xq. Biochemistry. 2007 Apr 17;46(15):4522-31. doi: 10.1021/bi0622468. Epub 2007 Mar 24. Biochemistry. 2007. PMID: 17381074 Free PMC article.

2

Disulfide bond structure and accessibility of cysteines in the ectodomain of the cholecystokinin receptor: specific mono-reactive receptor constructs examine charge-sensitivity of loop regions.

Ding XQ, Dolu V, Hadac EM, Schuetz M, Miller LJ. Ding XQ, et al. Recept Channels. 2003;9(2):83-91. Recept Channels. 2003. PMID: 12916469

3

Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist.

Arlander SJ, Dong M, Ding XQ, Pinon DI, Miller LJ. Arlander SJ, et al. Among authors: ding xq. Mol Pharmacol. 2004 Sep;66(3):545-52. doi: 10.1124/mol.104.001396. Mol Pharmacol. 2004. PMID: 15322246

4

Characterization of the type A cholecystokinin receptor hormone-binding domain: use of contrasting and complementary methodologies.

Ding XQ, Miller LJ. Ding XQ, et al. Peptides. 2001 Aug;22(8):1223-8. doi: 10.1016/s0196-9781(01)00445-4. Peptides. 2001. PMID: 11457514 Review.

5

Insights into the molecular basis of ligand binding by the cholecystokinin receptor.

Miller LJ, Ding XQ. Miller LJ, et al. Among authors: ding xq. Pancreatology. 2001;1(4):336-42. doi: 10.1159/000055832. Pancreatology. 2001. PMID: 12120212 Review.

6

Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor.

Ding XQ, Pinon DI, Furse KE, Lybrand TP, Miller LJ. Ding XQ, et al. Mol Pharmacol. 2002 May;61(5):1041-52. doi: 10.1124/mol.61.5.1041. Mol Pharmacol. 2002. PMID: 11961122

7

Spatial approximation between a photolabile residue in position 13 of secretin and the amino terminus of the secretin receptor.

Zang M, Dong M, Pinon DI, Ding XQ, Hadac EM, Li Z, Lybrand TP, Miller LJ. Zang M, et al. Among authors: ding xq. Mol Pharmacol. 2003 May;63(5):993-1001. doi: 10.1124/mol.63.5.993. Mol Pharmacol. 2003. PMID: 12695527

8

Dong M, Ding XQ, Pinon DI, Hadac EM, Oda RP, Landers JP, Miller LJ. Dong M, et al. Among authors: ding xq. J Biol Chem. 1999 Feb 19;274(8):4778-85. doi: 10.1074/jbc.274.8.4778. J Biol Chem. 1999. PMID: 9988716 Free article.

9

Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe.

Ding XQ, Dolu V, Hadac EM, Holicky EL, Pinon DI, Lybrand TP, Miller LJ. Ding XQ, et al. J Biol Chem. 2001 Feb 9;276(6):4236-44. doi: 10.1074/jbc.M003798200. Epub 2000 Oct 24. J Biol Chem. 2001. PMID: 11050076 Free article.

10

Impaired resensitization and recycling of the cholecystokinin receptor by co-expression of its second intracellular loop.

Ding XQ, Rao RV, Kuntz SM, Holicky EL, Miller LJ. Ding XQ, et al. Mol Pharmacol. 2000 Dec;58(6):1424-33. doi: 10.1124/mol.58.6.1424. Mol Pharmacol. 2000. PMID: 11093782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters